CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $182,793
- in 3 filings
Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-26 | Schoenberg Mark Chief Medical Officer | Exercise or conversion | +208 | 19,444 | ||
| 2020-10-26 | Schoenberg Mark Chief Medical Officer | Sale | −101 | $20.95 | $2K | 19,343 |
| 2020-10-26 | Schoenberg Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −208 | 1,042 | ||
| 2020-10-15 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion | +4,917 | 12,805 | ||
| 2020-10-15 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −976 | $21.80 | $21K | 11,829 |
| 2020-10-15 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −407 | $21.82 | $9K | 11,422 |
| 2020-10-15 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −1,017 | $21.72 | $22K | 10,405 |
| 2020-10-15 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −833 | 1,667 | ||
| 2020-10-15 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −2,084 | 2,082 | ||
| 2020-10-15 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −2,000 | 4,000 | ||
| 2020-10-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion | +8,808 | 201,501 | ||
| 2020-10-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −8,808 | 132,112 | ||
| 2020-10-01 | Henderson Molly Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2020-10-01 | Henderson Molly Chief Financial Officer | Grant or award · Restricted Stock Units | +15,000 | 15,000 | ||
| 2020-10-01 | Smith Jason Drew General Counsel | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2020-10-01 | Smith Jason Drew General Counsel | Grant or award · Restricted Stock Unit | +25,000 | 25,000 | ||
| 2020-09-09 | Smith Jason Drew General Counsel | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2020-09-09 | Smith Jason Drew General Counsel | Grant or award · Restricted Stock Unit | +25,000 | 25,000 | ||
| 2020-09-04 | Schoenberg Mark Chief Medical Officer | Exercise or conversion | +1,041 | 19,584 | ||
| 2020-09-04 | Schoenberg Mark Chief Medical Officer | Sale | −348 | $20.20 | $7K | 19,236 |
Page 19 of 25 · 496 trades